Certara is dedicated to improving human health by offering a broad spectrum of software products and services, with special focus on supporting translational approaches to drug development.
Certara is dedicated to improving healthcare by shortening the time it takes to successfully bring a new drug to market. We do this offering a broad spectrum of scientific consulting services and software products, with special focus on model based drug discovery and development.
Certara was formed by acquiring and integrating Tripos, Pharsight, and Simcyp, complementary companies focused on model-based approaches in different phases of the drug discovery and development cycle, creating a company with unparalleled scientific and technical breadth from early drug discovery through Phase IV clinical trials. Because of this, Certara is uniquely able to bring solutions forward that span the entire discovery and development cycle, eliminating traditional bottlenecks and impediments.
From Discovery through Development
Certara's goal is to provide solutions in predictive science, communication and informatics that facilitate the elimination of barriers to bi-directional sharing of information. Learn More